Prospective randomized comparison between omega-3 fatty acid supplements plus simvastatin versus simvastatin alone in Korean patients with mixed dyslipidemia: lipoprotein profiles and heart rate variability

被引:19
|
作者
Kim, Sang-Hyun [2 ,3 ]
Kim, Min-Kyung [2 ,4 ]
Lee, Hae-Young [2 ]
Kang, Hyun-Jae [2 ]
Kim, Yong-Jin [2 ]
Kim, Hyo-Soo [1 ,2 ]
机构
[1] Seoul Natl Univ Hosp, Div Cardiol, Dept Internal Med, Ctr Cardiovasc, Seoul 110744, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 151, South Korea
[3] Seoul Metropolitan Boramae Hosp, Ctr Cardiovasc, Seoul, South Korea
[4] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Seoul 110744, South Korea
关键词
omega-3 fatty acid; statin; lipoproteins; heart rate variability; N-3; FATTY-ACIDS; C-REACTIVE PROTEIN; FAMILIAL COMBINED HYPERLIPIDEMIA; CORONARY-ARTERY DISEASE; MYOCARDIAL-INFARCTION; HYPERCHOLESTEROLEMIC PATIENTS; BAROREFLEX SENSITIVITY; ATORVASTATIN; ASSOCIATION; CHOLESTEROL;
D O I
10.1038/ejcn.2010.195
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: This study was designed to evaluate the effects of omega-3 fatty acids supplements and simvastatin on lipoproteins and heart rate variability (HRV), a surrogate parameter of cardiac autonomic function, in patients with mixed dyslipidemia. Methods: This study was a prospective, randomized, open-label study. Among the 171 patients screened, 62 who met the inclusion criteria after 6 weeks on a strict diet therapy were randomized into two treatment groups. The inclusion criteria were mixed dyslipidemia with a high triglyceride level (200-499mg per 100 ml) and a total cholesterol level >200mg per 100 ml. After a run-in period of 6 weeks, the patients were randomized into two groups and given a combination treatment with 4 g of omega-3 fatty acids (four 1 g Omacor (eicosapentaenoic acid, 465 mg; docosahexaenoic acid, 375 mg; other omega-3 fatty acids, 60 mg; others 100 mg, Gun-il Pharmacy, Seoul, Korea)) and 20mg of simvastatin daily or a monotherapy of 20mg simvastatin for 6 weeks. In the combination therapy group, seven patients dropped out, and in the simvastatin alone therapy group, five patients dropped out during the study period. Results: After 6 weeks of drug treatment, triglyceride levels decreased by 41.0% in the combination treatment group and 13.9% in the simvastatin monotherapy group (from 309.2 +/- 95 mg per 100 ml to 177.7 +/- 66 versus 294.6 +/- 78 mg per 100 ml to 238.3 +/- 84 mg per 100 ml, respectively, P=0.0007). No significant changes in the HRV parameters were observed in either group. Conclusion: The combination of omega-3 fatty acids plus simvastatin, which achieved a significantly greater reduction of triglycerides without adverse reactions, should be considered as an optimal treatment option for patients with mixed dyslipidemia. European Journal of Clinical Nutrition (2011) 65, 110-116; doi:10.1038/ejcn.2010.195; published online 29 September 2010
引用
收藏
页码:110 / 116
页数:7
相关论文
共 13 条
  • [1] Prospective randomized comparison between omega-3 fatty acid supplements plus simvastatin versus simvastatin alone in Korean patients with mixed dyslipidemia: lipoprotein profiles and heart rate variability
    Sang-Hyun Kim
    Min-Kyung Kim
    Hae-Young Lee
    Hyun-Jae Kang
    Yong-Jin Kim
    Hyo-Soo Kim
    [J]. European Journal of Clinical Nutrition, 2011, 65 : 110 - 116
  • [2] Effects of Omega-3 Fatty Acids on Lipoprotein Profiles and Heart Rate Variability in Patients with Mixed Dyslipidemia
    Kim, Sang-Hyun
    Chung, Woo-Young
    Zo, Joo-Hee
    Kim, Myung-A
    Kim, Yong-Jin
    Kang, Hyun-Jae
    Kim, Hyo-Soo
    Sohn, Dae-Won
    Oh, Byung-Hee
    Park, Young-Bae
    [J]. CIRCULATION, 2009, 119 (10) : E292 - E293
  • [3] EFFECTS OF OMEGA-3 FATTY ACIDS ON LIPOPROTEIN PROFILES AND HEART RATE VARIABILITY IN PATIENTS WITH MIXED DYSLIPIDEMIA
    Kim, S. H.
    Lee, H. Y.
    Chung, W. Y.
    Zo, J. H.
    Kim, M. A.
    Kim, H. S.
    Kim, C. H.
    Sohn, D. W.
    Oh, B. H.
    Park, Y. B.
    Choi, Y. S.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [4] Effects of Simvastatin alone versus Fenofibrate alone versus Simvastatin plus Fenofibrate on lipoprotein subparticle profiles in patients with diabetes mellitus and mixed dyslipidemia
    Athyros, Vasilios G.
    Kakafika, Anna I.
    Koragiannis, Asterios
    Mikhalidis, Dirnitri P.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (11): : 1679 - 1680
  • [5] Comparison of effects of Simvastatin alone versus Fenofibrate alone versus Simvastatin plus Fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the diabetes and combined lipid therapy regimen study)
    May, Heidi T.
    Anderson, Jeffrey L.
    Pearson, Robert R.
    Jensen, Jonathan R.
    Horne, Benjamin D.
    Lavasani, Farangis
    Yannicelli, H. Daniel
    Muhlestein, Joseph B.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (04): : 486 - 489
  • [6] Effects of Simvastatin alone versus Fenofibrate alone versus Simvastatin plus Fenofibrate on lipoprotein subparticle profiles in patients with diabetes mellitus and mixed dyslipidemia (vol 101, pg 1679, 2008)
    Athyros, Vasilios G.
    Kakafika, Anna I.
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (02): : 248 - 248
  • [7] Prescription omega-3 acid ethyl esters plus simvastatin 20 and 80 mg: effects in mixed dyslipidemia
    Maki, Kevin C.
    Lubin, Barry C.
    Reeves, Matthew S.
    Dicklin, Mary R.
    Harris, William S.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2009, 3 (01) : 33 - 38
  • [8] Effects of adding prescription omega-3 acid ethyl esters to simvastatin (20 mg/day) on lipids and lipoprotein particles in men and women with mixed dyslipidemia
    Maki, Kevin C.
    McKenney, James M.
    Reeves, Matthew S.
    Lubin, Barry C.
    Dicklin, Mary R.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (04): : 429 - 433
  • [9] Omega-3 fatty acid ethyl esters increase heart rate variability in patients with coronary disease
    Villa, B
    Calabresi, L
    Chiesa, G
    Risè, P
    Galli, C
    Sirtori, CR
    [J]. PHARMACOLOGICAL RESEARCH, 2002, 45 (06) : 475 - 478
  • [10] An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia
    Durrington, PN
    Bhatnagar, D
    Mackness, MI
    Morgan, J
    Julier, K
    Khan, MA
    France, M
    [J]. HEART, 2001, 85 (05) : 544 - 548